Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review
- PMID: 31208364
- PMCID: PMC6580464
- DOI: 10.1186/s12881-019-0836-5
Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review
Abstract
Background: Citrullinemia type I (CTLN1) is a rare autosomal recessive disorder of the urea cycle caused by a deficiency in the argininosuccinate synthetase (ASS1) enzyme due to mutations in the ASS1 gene. Only a few Chinese patients with CTLN1 have been reported, and ASS1 gene mutations have been identified sporadically in China.
Case presentation: A Chinese family with one member affected with mild CTLN1 was enrolled. Targeted exome sequencing was performed on the proband, and Sanger sequencing was used to validate the detected mutation. We also reviewed the genetic and clinical characteristics of CTLN1 in Chinese patients that have been published to date. Newborn screening showed remarkably increased concentrations of citrulline with elevated ratios of citrulline/arginine and citrulline/phenylalanine, and the patient presented with a speech delay at age three. The urinary organic acid profiles were normal. A novel homozygous splicing variant c.773 + 4A > C in the ASS1 gene was identified in the proband, and it was predicted to affect splicing by in silico analysis. To date, only nine Chinese patients with CTLN1 have been reported, with a total of 15 ASS1 mutations identified and no high frequency or hot spot mutations found; the mutation spectrum of Chinese patients with CTLN1 was heterogeneous.
Conclusions: We described a mild Chinese CTLN1 case with a novel homozygous splicing variant c.773 + 4A > C and reviewed previous genotypes and phenotypes in Chinese patients with CTLN1. Thus, our findings contribute to understanding the molecular genetic background and clinical phenotype of CTLN1 in this population.
Keywords: ASS1; Citrullinemia type I; Mutation spectrum; Novel variant.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Functional analysis of novel splicing and missense mutations identified in the ASS1 gene in classical citrullinemia patients.Clin Chim Acta. 2015 Jan 1;438:323-9. doi: 10.1016/j.cca.2014.08.028. Epub 2014 Aug 30. Clin Chim Acta. 2015. PMID: 25179242
-
Identification of three novel mutations in fourteen patients with citrullinemia type 1.Clin Biochem. 2017 Aug;50(12):686-689. doi: 10.1016/j.clinbiochem.2017.01.011. Epub 2017 Jan 27. Clin Biochem. 2017. PMID: 28132756
-
Mutation spectrum of the ASS1 gene in Korean patients with citrullinemia type I.Clin Biochem. 2013 Feb;46(3):209-13. doi: 10.1016/j.clinbiochem.2012.10.008. Epub 2012 Oct 22. Clin Biochem. 2013. PMID: 23099195
-
Molecular genetics of citrullinemia types I and II.Clin Chim Acta. 2014 Apr 20;431:1-8. doi: 10.1016/j.cca.2014.01.032. Epub 2014 Feb 5. Clin Chim Acta. 2014. PMID: 24508627 Review.
-
Mutations in the Human Argininosuccinate Synthetase (ASS1) Gene, Impact on Patients, Common Changes, and Structural Considerations.Hum Mutat. 2017 May;38(5):471-484. doi: 10.1002/humu.23184. Epub 2017 Feb 15. Hum Mutat. 2017. PMID: 28111830 Review.
Cited by
-
Modelling urea cycle disorders using iPSCs.NPJ Regen Med. 2022 Sep 26;7(1):56. doi: 10.1038/s41536-022-00252-5. NPJ Regen Med. 2022. PMID: 36163209 Free PMC article. Review.
-
Citrullinemia type I in Chinese children: Identification of two novel argininosuccinate synthetase gene mutations.Front Pediatr. 2022 Oct 3;10:992156. doi: 10.3389/fped.2022.992156. eCollection 2022. Front Pediatr. 2022. PMID: 36263152 Free PMC article.
-
Prenatal diagnosis of citrullinemia type 1; seven families with c.1168G A mutation of Argininosuccinate synthetase 1 gene in Southwest Iran: A case series.Int J Reprod Biomed. 2023 Jan 9;20(12):1047-1050. doi: 10.18502/ijrm.v20i12.12567. eCollection 2022 Dec. Int J Reprod Biomed. 2023. PMID: 36819208 Free PMC article.
-
Identification of Novel Mutations in Chinese Infants With Citrullinemia.Front Genet. 2022 Mar 3;13:783799. doi: 10.3389/fgene.2022.783799. eCollection 2022. Front Genet. 2022. PMID: 35309121 Free PMC article.
-
Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.Nat Commun. 2021 Apr 15;12(1):2263. doi: 10.1038/s41467-021-22235-8. Nat Commun. 2021. PMID: 33859183 Free PMC article.
References
-
- Beaudet AL, O'Brien WE, Bock HG, Freytag SO, Su TS. The human argininosuccinate synthetase locus and citrullinemia. Adv Hum Genet. 1986;15:161–196. - PubMed
-
- Haberle J, Pauli S, Linnebank M, Kleijer WJ, Bakker HD, Wanders RJ, Harms E, Koch HG. Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia. Hum Genet. 2002;110(4):327–333. doi: 10.1007/s00439-002-0686-6. - DOI - PubMed
-
- Sander J, Janzen N, Sander S, Steuerwald U, Das AM, Scholl S, Trefz FK, Koch HG, Haberle J, Korall H, et al. Neonatal screening for citrullinaemia. Eur J Pediatr. 2003;162(6):417–420. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous